FDA warned Kabana Skin Care that its "Kabana Body Wash +UV" is an unapproved, misbranded sunscreen drug sold without required FDA clearance.
What happened
In June 2024 FDA reviewed the company's product labeling and its website, kabanaskincare.com, where "Kabana Body Wash +UV" is offered for sale. FDA found website statements and customer testimonials saying the body wash provides UV protection, which FDA treats as marketing the product as an over-the-counter (OTC) sunscreen drug. FDA said no approved drug application exists for it, and sunscreens in body wash form are not among the dosage forms allowed to be sold without approval.
What FDA found
The product is a drug because its labeling claims it prevents sun damage and affects how the body responds to UV light.
Section 201(g)(1)(B) and (C) of the FD&C Act, 21 U.S.C. 321(g)(1)(B) and (C)It is a new drug sold without an FDA-approved application.
Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)It is misbranded because it is sold as a nonprescription drug without meeting the rules for marketing without approval.
Section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)A body wash is not one of the dosage forms FDA allows for sunscreen sold without approval (oil, lotion, cream, gel, butter, paste, ointment, stick, spray, powder), and no FDA order permits it.
Section 505G(m)(2) of the FD&C Act, 21 U.S.C. 355h(m)(2)Shipping the product across state lines is prohibited.
Sections 301(a) and (d) of the FD&C Act, 21 U.S.C. 331(a) and (d)
What FDA wants
FDA asks the company to write within 15 working days describing the specific steps taken to fix the violations and prevent them from recurring, with supporting documents. If the company believes it is not in violation, it should send its reasoning and evidence to FDAAdvisory@fda.hhs.gov.
Who should pay attention
- online skin care and cosmetics sellers making UV or SPF claims
- brands selling sunscreen in unusual forms such as body wash, wipes or shampoo
- contract manufacturers and labelers of OTC sunscreen products
This is a summary. Read the original letter on fda.gov.